Epichlor 50 Injection
Marketer
Khandelwal Laboratories Pvt Ltd
Salt Composition
Epirubicin (50mg)
Overview Epichlor 50 Injection
Epichloor 50 Injection treats various hematologic malignancies and cancers affecting the breast, stomach, lungs, ovaries, and soft tissues. It also aids in preventing bladder cancer relapse post-surgery. Administered intravenously by a healthcare professional, this medication may be used alone or in conjunction with other drugs as part of a chemotherapy regimen. Dosage and frequency are determined by your physician based on your condition and may adjust over time. Strict adherence to your doctor's instructions is crucial; incorrect usage or overdosage can result in severe adverse reactions. While therapeutic benefits may take weeks or months to manifest, discontinue use only as directed by your physician. This medication reduces contraceptive efficacy; reliable contraception is recommended for both men and women during treatment. Common side effects include nausea, thrombocytopenia, alopecia, amenorrhea, pyrexia, and skin rashes. The medication's effect on blood cell counts increases infection risk, potentially life-threatening. Regular blood tests are necessary to monitor blood cell counts, renal, hepatic, and cardiac function. Prior to treatment, disclose any liver or heart conditions, and list all other medications being taken, as drug interactions may affect Epichloor 50's effectiveness or mechanism of action. Inform your physician if you are pregnant or lactating.
Uses of Epichlor 50 Injection
Malignant neoplasm
Major Benefits of Epichlor 50 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Epichlor 50 Injection:
- Low blood platelets
- Nausea
- Hair loss
- Absence of menstrual periods
- Fever
- Anemia (low number of red blood cells)
- Diarrhea
- Weight loss
- Decreased white blood cell count (neutrophils)
- Hot flashes
- Gastrointestinal inflammation
- Rash
- Low energy
- Eye disorder
How to use Epichlor 50 Injection:
Administering this medication will be handled by your physician or registered nurse; self-medication is strictly prohibited.
How Epichlor 50 Injection works:
Epichlor 50 Injection is a cancer treatment that inhibits topoisomerase II, an enzyme crucial for breast cancer cell DNA replication. This inhibition, coupled with the drug's generation of damaging free radicals, disrupts DNA integrity, thus impeding breast cancer cell proliferation and ultimately leading to their demise.
SAFETY ADVICE
AlcoholUNSAFE
Alcohol consumption alongside Epichlor 50 Injection is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Administering Epichlor 50 Injection to pregnant individuals poses a confirmed risk to the fetus. Therefore, its use during pregnancy is contraindicated. Nevertheless, a physician might exceptionally prescribe it in critical circumstances where the potential advantages outweigh the hazards. Seek medical counsel before use.
Breast feedingUNSAFE
Administering Epichlor 50 Injection while breastfeeding is contraindicated due to potential infant toxicity. Research indicates a risk of harm to the nursing infant.
DrivingUNSAFE
Driving ability may be compromised by side effects of Epichlor 50 Injection. Nausea and vomiting, potential side effects of Epichlor 50 Injection, can temporarily hinder safe driving.
KidneySAFE IF PRESCRIBED
The use of Epichlor 50 Injection in individuals with kidney impairment appears to pose minimal risk. Existing evidence indicates dose modification may be unnecessary; however, professional medical advice is recommended. For patients exhibiting serum creatinine levels exceeding 5 mg/dL, reduced dosages should be evaluated.
LiverCAUTION
Patients with liver impairment should receive Epichlor 50 Injection cautiously, potentially requiring dosage modification. Severe hepatic dysfunction contraindicates Epichlor 50 Injection; physician consultation is advised.
What if you forget to take Epichlor 50 Injection :
NA
Facts to Know About Epichlor 50 Injection
| Label | Value |
|---|---|
| Chemical Type | Anthracycline-based drug |
| Developing Habits | No. |
| Type of Therapy | Cancer Medications |
| Behavior Class | Cytotoxic alkaloids |


